BALA MOHAN (SVP, Chief Development Officer) sold 7.9% of their position (5.94K shares) of MERSANA THERAPEUTICS, INC. on the open market
Open‑market sale worth $3.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/17/2025ACC: 0001104659-25-004590
Officer· SVP, Chief Development Officer
Since Sep 2023
+337.81K
Net shares
Net buyer
$3.4K
Total sold
1
Open market trades
0B · 1S
5
Total transactions
358.33K acquired · 20.52K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+14.58K
Price / share
—
Trade value
—
% of position
24.2%
1/15/2025
60.23K→74.81K
Common Stock
Direct
Shares
−5.94K
Price / share
$0.58
Trade value
$3.44K
% of position
7.9%
1/16/2025
74.81K→68.87K
Total
Net shares
+8.64K
Net value
-$3.44K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/15/2025 | M · Option Exercise | +14.58K | — | — | 24.2% | 60.23K | 74.81K |
| Common Stock Direct | 1/16/2025 | S · Sale | −5.94K | $0.58 | $3.44K | 7.9% | 74.81K | 68.87K |
| Total | +8.64K | -$3.44K | ||||||
Derivative Transactions3
Restricted Stock Unit
Direct
Converts to
Common Stock
14.58K shares
Shares
−14.58K
Strike price
Held after
43.75K
Exercisable
—
1/15/2025
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
281.25K shares
Shares
+281.25K
Strike price
0.64
Held after
281.25K
Exercisable
—
1/15/2025
Restricted Stock Unit
Direct
Converts to
Common Stock
62.50K shares
Shares
+62.50K
Strike price
Held after
62.50K
Exercisable
—
1/15/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock14.58K shares | 1/15/2025 | M · Option Exercise | −14.58K | — | 43.75K | |
| Stock Option (Right to Buy) Direct | Common Stock281.25K shares | 1/15/2025 | A · Award | +281.25K | 0.64 | — | 281.25K |
| Restricted Stock Unit Direct | Common Stock62.50K shares | 1/15/2025 | A · Award | +62.50K | — | 62.50K |